TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry
This article was originally published in The Pink Sheet Daily
Executive Summary
The only elevated cancer type in patients taking the biologic drugs was non-melanoma skin cancer, investigator reports at rheumatology scientific conference.
You may also be interested in...
Cimzia Rheumatoid Arthritis Approval Held Up By Safety Request
UCB receives “complete response” letter from FDA on second indication for the biologic, approved for Crohn’s disease with a REMS.
Cimzia Rheumatoid Arthritis Approval Held Up By Safety Request
UCB receives “complete response” letter from FDA on second indication for the biologic, approved for Crohn’s disease with a REMS.
Anti-TNFs’ Link To Cancer In Children Under Investigation By FDA
Agency is investigating approximately 30 reports of cancer in pediatric patients.